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THE production of acute phase cytokines, interleukin
6  (IL-6),  tumour  necrosis  factor  (TNFa )  and  inter-
leukin 1 (IL-1b ), was studied in primary cultures of
human skin fibroblasts, human monocytic cell line
U937 and primary cultures of human umbilical vein
endothelial cells (HUVEC) after in vitro infection with
vaccinia  virus.  Significant  increase  in  IL-6  mRNA
followed  by  enhanced  protein  secretion  into  the
culture  media  was  found  in  fibroblasts,  U937 cells,
and HUVEC. TNFa increased production in vaccinia
virus infected U937 cells resembled closely the pat-
tern of IL-6 production observed in the infected cells.
Transient  increase  in  NF-k B  binding  activity  was
found in the infected U937 (at 90 min) and endothelial
(at  30 min)  cells.  Vaccinia  virus  induced  cytokine
production appeared to be transcriptional.
Key words: Vaccinia virus, Acute phase cytokines, Fibro-
blasts, U937, HUVEC
Introduction
Vaccinia virus (VV) belongs to the poxviruses super-
family, a group of large DNA viruses known from their
exclusive propagation within the cytoplasm of eukar-
yotic  cells. VV  infections  are  commonly  associated
with a generalized host cell protein and nucleic acids
synthesis inhibition. The shut down of host transcrip-
tional and translational machineries is done in favour
of  selective  expression  of  viral  genes.1,2 However,
several groups of eukaryotic proteins are transiently
induced  by  many  viruses  in  infected  cells,  e.g.
cytokines (TNFa , IL-6, INFg ),3,4 heat shock proteins
(mouse hsp72)5 and transcription factors (NF-k B).6
Viral infections are accompanied by dysregulation
of  cytokine  production  and  virus-cytokines  inter-
actions  appear  to  be  complex  as  cytokines  by
themselves possess pleiotropic activities. Induction of
a cytokine,  a cytokine receptor  or a growth  factor
production  by  a  virus  could  stimulate  its  own
replication and infectious virus production (like IL-8
for  HCMV).7 Some  cytokines  might  also  help  to
escape  immune  responses  if  a  cytokine  exerts  a
negative effect on the immune system (like Epstein-
Barr  virus  encoded  IL-10,  typical  antiinflammatory
cytokine).8 Therefore, reduction of proinflammatory
cytokines production, like IL-1 and TNFa , having not
only  direct  antiviral  effect  (like  TNFa )  but  also
coordinating  the  host  inflammatory  and  immune
responses  to  viral  infection,  could  lead  to  viral
infection progression.9
DNA  viruses  like  vaccinia  and  other  orthopox-
viruses,  possessing  large  genomes,  acquired  anti-
cytokine defense mechanisms encompassing expres-
sion of soluble cytokine receptor genes and cytokine
converting  enzymes.10 Thus,  virus  encoded  several
cytokine response modifiers (like crm A) act together
to inhibit the release of proinflammatory cytokines in
response to infection.11
To further understand the biology of vaccinia virus
and virally induced acute phase response, acute phase
inflammatory  cytokines  were  measured  in  three
infected human cell types: primary cultures of skin
fibroblasts,  the  promonocytic  cell  line  U937  and
umbilical vein endothelial cells.
Materials and Methods
Cells and viruses
The WR strain of vaccinia virus was propagated on
Vero cells infected at multiplicity of infection (MOI)
1:1 (one plague forming unit per cell), maintained in
MEM  supplemented  with  4%  heat-inactivated  FCS.
Infected cells were harvested at maximum cytopathic
effect and infectivity estimated by quantal infectivity
assay on Vero cells.12
Human  skin  fibroblasts  were  cultured  in  MEM
containing 10%  FCS, 2mM glutamine and antibiotic–
antimycotic  mixture  (passage  3–12  was  used). For
RNA extraction cells were grown in 84mm diameter
culture dishes in the density of 1.8 3 106 cells/dish in
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production,  LPS  (lipopolysaccharide  from  Escher-
ichia  coli 026:B6,  Sigma)  in concentration  1m g/ml
and IL-1a (10ng/ml) were used.
U937 cells were grown in RPMI supplemented with
8% FCS and antibiotics. The experiments were carried
out on U937 cells differentiated into a macrophage-
like cells in the presence of 50nM phorbol myristate
acetate (PMA) for 24–36h. Adherent cells (in RPMI
with 4%  FCS without PMA) were infected or treated
with LPS for an additional 6–24h.
Endothelial cells were isolated from human umbil-
ical cord veins. Umbilical veins from individual cords
were cannulated, washed with HBSS without Ca and
Mg and filled with 0.1%  collagenase type I in HBSS
with Ca and Mg. After a 15-min incubation at 37°C,
the  detached  cells  were  collected  and  washed  by
three times repeated centrifugation and resuspended
in M199 containing 20% heat-inactivated FCS, heparin
(10U/ml), HEPES (15mM), 1% gentamycin and endo-
thelial  cell  growth  supplement  (ECGS)  (50m g/ml).
Cells from passages 2 to 4 were grown on 5% gelatin-
precoated 60-mm culture dishes.
All  cultures  were  infected with  vaccinia  virus  at
MOI 1:1, 2:1 or 4:1 (as indicated in the figure legends)
at the time of LPS addition. Mock infected (control)
cultures  were  prepared  in  the  same  way.  Infected
cells were washed after 1-h virus adsorption and fresh
medium  added. Effectiveness  of  infection  was  rou-
tinely checked by microscopic examination at 24h
postinfection (p.i.) and typical rounding of infected
cells was observed. Higher infectious doses than the
doses used would result in profound cytopathic effect
at 24–48h.
The  viability  of  the  cells  was  routinely  checked
using fluorescein diacetate/ethidium bromide double
fluorescent test.
Cytokine assay
TNFa ,  IL-1b and  IL-6  proteins  were  determined in
culture media using commercially available ELISA kits
(Genzyme).
Statistical significance of the differences between
means was estimated using Fisher-Behrens test.
RNA extraction and northern blot analysis
Total  RNA was  extracted from  cultured cells  using
standard phenol-chloroform method and LiCl precip-
itation.13 RNA samples (10m g) were separated elec-
trophoretically  in 1%   agarose  gel  under  denaturing
conditions.
14 RNA was then transferred to hybond-N
membranes (Amersham, UK). The blots were baked at
80°C for 2h and prehybridized 1–3h. Specific mRNAs
were  detected  by  hybridization  at  68°C  in  10%
dextran  sulfate,  1M  NaCl  and  1%  SDS  with  1.2kb
EcoRI–Hindlll fragment of human IL-6 cDNA (kindly
donated by Dr T . Kishimoto), or 1.1kb Pstl fragment
of human TNFa (ATCC, Rockville, MD) labelled with
32P-dCTP by random priming.
Reverse transcriptase-PCR
cDNA synthesis reactions were done in a total volume
of 20m l containing 10m l of each RNA sample (0.5 or
1m g), 0.5m g oligo(dT)12–18 primer (Gibco) and 200 U
of  SuperScriptTMll  RNAse  H-Reverse  Transcriptase
(Gibco) according to the protocol provided with the
enzyme. PCRs were set up in a total volume of 50m l
containing  5m l of  the cDNA, 0.2mM  deoxynucleo-
side  triphosphate,  0.5m M  of  each  oligonucleotide
primer, 50mM KCI, 1.5mM MgCl2, and 2.5U of Taq
polymerase (Gibco). PCRs were run on 0.5ml tubes,
in  OmniGene  thermal  cycler  (Hybaid, Teddington,
UK) equipped with heated lid. Reactions were carried
out at the following conditions: 94°C for 1min, 60°C
for 1min, and 72°C for 1.5min. for 35 cycles (IL-6,
TNF-a ), or 94°C for 1min, 55°C for 1min, and 72°C
for  1.5min  for  35  cycles  (b -actin).  Each  thermal
profile  was  ended with final extension at 72°C for
10min. The reaction products were then resolved on
nondenaturing 2%  agarose (Sigma, St Louis, MO) gel
and visualized by staining with ethidium bromide.
The  following  PCR  primers  were  custom-synthe-
sized by Gibco:
TNFa (sense)
59 -ATGAGCACTGAAAGCATGATC-39 ;
(anti)
59 -GCAATGATCCCAAAGTAGACCTGCCC-39 ;
IL-6 (sense)
59 -CTTTTGGAGTTTGAGGTATACCTAG-39 ;
(anti)
59 -GCTGCGCAGAATGAGATGAGTTGTC-39 ;
b -actin (sense)
59 -AGCGGGAAATCGTGCGTG-39 ;
(anti)
59 -GGGTACATGGTGGTGCCG-39 .
All  primers  were  designed  to  match  sequences  in
separate exons to avoid the contribution of genome
templated product in the analysed signal. The expec-
ted product lengths are: 702bp for TNFa , 237bp for
IL-6 and 307bp for b -actin.
Electrophoretic mobility shift assay
Nuclear extracts were prepared from vaccinia virus
infected U937 cells and HUVEC by using the method
of Suzuki et al.15 Protein concentrations were deter-
mined by bicinchoninic method (Sigma) according to
manufacturer’s instruction.
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DNA  mobility  shift  assay  was  carried  out  as
described  by  Duyao  et  al.16 A  double  stranded
oligonucleotide  59 -AAGTCCGGGTTTTCCCCAACC-39
containing two repeats of NF-kB binding site, corre-
sponding  to  –1101  to  –1081bp  region  of  murine
c-myc16 was  synthesized  by  Molecular  and  Macro-
molecular Research  Center, L´ od´ z, Poland. The DNA
probe  was  end-labelled  by  using  polynucleotide
kinase and g -32P-ATP. Equal amounts of protein (5m g)
in 10% glycerol were incubated at room temperature
for 30min with  0.5ng  (~  105cpm)  of  the  labelled
dsDNA  oligonucleotide  in  the  presence  of  4m g  of
poly(dl-dC) in 10mM Tris pH 7.5, 50mM NaCl, 1mM
EDTA and 0.1mM DTT in a total  volume  of  25m l.
Some  samples  were  incubated  in  the  presence  of
100-fold molar excess of specific cold oligonucleotide
probe  as  a  competitor.  Incubation  mixtures  were
electrophoresed on 4.5% non-denaturing polyacryla-
mide gel in 0.5 3 TBE. The dried gels were analysed by
autoradiography.
Results
Vaccinia virus infection induces transcription
and secretion of IL-6 in human fibroblasts
Supernatants of infected human skin fibroblasts and
uninfected control fibroblasts were collected and IL-6
measured by ELISA, while the cells were used for total
RNA extraction. The representative experiment illus-
trated in Fig. 1A shows that vaccinia virus induced IL-
6  mRNA was  detected only early  post-infection (at
4h) and the transcript is not found after 6–48h p.i.
Despite this early message degradation, IL-6 protein
was detected in the culture media at all times p.i. and
even at 48h the cytokine was further increased by the
virus  (Fig.  1B).  Quantification  of  IL-6  showed  that
amounts  of  IL-6  induced  by  LPS  and  lower  doses
of VV  (MOI  of  1:1  and  2:1)  were  comparable,
however much higher infectious dose (MOI of 4:1)
caused larger increase  in cytokine  production  than
after LPS addition (Fig. 2A). While primary cultures of
human skin fibroblasts failed to produce detectable
amounts of TNFa , IL-1b was induced by LPS and VV as
well as by combination of LPS and VV (Fig. 2B). No
basal  IL-1b expression  level  was  found  in  control
cultures. Almost synergistic effect of the combination
of stimulants was found only for IL-1b (Fig. 2B), since
IL-6 induction was not further induced by LPS and VV
(Fig. 2A).
Cytokine production and viral infection
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FIG. 1. IL-6 gene expression in vaccinia virus-infected human
skin  fibroblasts.  Human  skin  fibroblasts  remained  either
untreated (control–C), or were infected with vaccinia virus
(V) (at MOI 2:1) or treated with LPS (L). After 4, 6 or 24h the
cells were harvested for RNA extraction. 10m g of total RNA
was applied per lane for Northern blot analysis with IL-6
specific cDNA  probe  (A). IL-6 protein  was  determined  by
ELISA in culture media from four separate experiments (6
and  24h)  and  a  single  experiment  (48h)  (B). Results are
expressed as the mean  ± standard  deviation.  Statistically
significant results and P values < 0.01 are marked by*.
FIG.  2.  Vaccinia  virus  and  LPS  effects  on  IL-6  and  IL-1b
secretion from human skin fibroblasts. IL-6 (A) and IL-1b (B)
secretion was evaluated by ELISA in control (C), vaccinia
virus infected (V–at MOI 4:1) and/or LPS treated (L) human
skin  fibroblasts  at  24h.  The  results  come  from  a  single
experiment.*
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Vaccinia virus infected human monocytic cell
line U937 produces increased TNFa and IL-6
PMA  differentiated  U937  cells  produced  increasing
amounts  of TNFa and  IL-6  mRNAs  as  well  as  the
proteins as estimated by RT -PCR and ELISA (Fig. 3A,B,
C). The cytokine was not detectable in fibroblast and
HUVEC cultures. Although IL-6 accumulation was still
enhanced  at  24h,  the  cytokine  transcripts  were
already decreased probably due to destability of the
mRNA  by  the  virus.  Increased  IL-6  mRNA  content
found in 24h control cultures seems to result from the
culture conditions. Similar changes were observed in
case  of  IL-1b and  IL-12  mRNAs  in  vaccinia  virus
infected U937 cells, while no change in IL-10 mRNA
was found in virally infected cells (data not shown).
Human endothelium exhibits early change in
IL-6 production
Vaccinia virus infected human umbilical vein endothe-
lial cells exhibit increased levels of IL-6 mRNA at 2h
(Fig.  4A)  and  moderate  IL-6  protein  stimulation
(statistically not significant) found at 6h (Fig. 4B).  Thus,
the production of IL-6 in primary cultures of endothe-
lial cells is stimulated by the virus earlier than in two
other cell types. NF-k B early activation in VV-infected
HUVEC (30min–Fig. 5B) supports the latter observa-
tion.  Vaccinia virus caused similar early increase in DNA
binding activity in U937 cells (Fig. 5A).
Discussion
Proinflammatory cytokines play an important role in
modulating  the  pathogenesis  of  viral  infections.9,17
Pleiotropic cytokines, like TNFa , IL-1b and IL-6, have
been established as potent inducers of an inflamma-
tory response with fever, acute phase protein synthe-
sis in the liver and cofactors of T and B lymphocyte
and macrophage activation.18 Little is known about
the regulatory role played by the cytokines in vaccinia
virus  infection.  Since  genetically  engineered  pox-
viruses are widely used for recombinant gene expres-
sion and vaccination,19 therefore its pathogenesis in
human tissues is of potencial interest. In this study,
the  capacity  of  three  types  of  human  cell  lines  to
produce  acute  phase  cytokines  following  vaccinia
virus infection, was tested.
Fibroblasts,  that  do not  classically  belong  to  the
immune  system,  produce  IL-6  and  IL-1  that  can
influence the local and systemic reactions observed
during host defense against viral infections. Increased
production of  IL-6 and IL-1b found  in the infected
cells  in  culture  (Figs  1  and  2),  suggests  that  the
cytokines may play an important role in the pathogen-
esis of VV . Excessive amounts of IL-1b produced by
human skin fibroblasts during vaccinia virus infection
could be bound with high  affinity by the VV IL-1b
H. Rokita et al.
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FIG. 3. Changes in TNFa and IL-6 gene expression in vaccinia
virus infected U937 cells. TNFa , IL-6 and b -actin mRNAs were
measured by RT-PCR (A) and the cytokines secretion deter-
mined by ELISA (TNFa –B; IL-6–C). RT-PCR data come from a
single representative experiment, whereas cytokine proteins
were analysed in culture media from three experiments and
standard  deviation shown where it was possible. Vaccinia
virus infection was at MOI 1:1. C–control cultures, V–vaccinia
virus infected cultures, L–LPS-treated cultures (performed as
a  positive  control).  Results  are expressed as  the mean  ±
standard  deviation.  Statistically  significant  results  and  P
values < 0.01 are marked by*.*
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receptor  encoded  by  gene  B15R  in  the  Western
Reserve (WR) strain.20 However, no mechanism for IL-
6 neutralization was found in vaccinia virus so far.
Amongst its pleiotropic effects, TNFa possesses a
remarkable  antiviral  activity  and  the  ability  to  kill
virus-infected cells.21 On the other hand, a role for
TNF in activation of human immunodeficiency virus
replication was found.22 In our studies, vaccinia virus
induced profound increase in TNFa production only
in  the  monocytic  cell  line  U937  (Fig.  3A  and  B),
whereas  no detectable  levels of  the  cytokine  were
found in fibroblasts and endothelial cells. Our results
demonstrate  that  vaccinia  virus  induce TNFa tran-
scriptionally,  although  translational  control  of TNF
production  was  found  by  others.3 Cowpox  virus
encoded  soluble  TNF  receptor  (crmC)  is  able  to
Cytokine production and viral infection
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FIG. 4. Effect of vaccinia virus infection on IL-6 expression in
human endothelial cells. IL-6 mRNA was measured for 6 and
24h  samples  by  hybridization  with  human  cDNA  probe
giving also unspecific signal with 18S rRNA. Additionally, 2,
4 and 6h RNA samples were analysed by RT-PCR (A). The
cytokine  protein  was  determined by  ELISA  in the culture
media from three separate experiments and expressed in ng/
ml of medium and 106 cells. Vaccinia virus infection was at
MOI 2:1. LPS-stimulated cultures were used as the positive
control. p.i.–post infection; p.s.–post stimulation. Results are
expressed as the mean  ± standard  deviation.  Statistically
significant results and P values < 0.01 are marked by*.
FIG. 5. Vaccinia virus inducible NF-k B binding activity in U937
and  HUVEC.  Double-stranded  oligonucleotide  comprising
NF-k B site was incubated with nuclear extracts isolated from
control (C) and vaccinia virus (V) infected U937 cells (MOI
1:1)  (A)  or  HUVEC  (MOI  2:1)  (B).  V*–100-fold  excess  of
unlabelled  dsDNA oligonucleotide added as a competitor.
Specific complexes and free probes are indicated.inhibit host-elicited TNF .23 The stimulatory  effect of
VV on the cytokine production places vaccinia virus
in the  group  of other TNFa inducers.9,24 However,
other viruses, e.g. EBV , inhibit TNF transcription.25
Three other cytokines were preliminary estimated
in infected monocytes by RT -PCR: IL-12, IL-1b and IL-
10.  IL-1b and  IL-12  both  act  as  proinflammatory
cytokines  and  additionally  IL-12  promotes  Th1-
dependent  resistance  to  infections  by  different
agents.26 On the other hand, IL-10, known from its
suppressing  effect  on cytokine  production by HIV-
infected macrophages and T cells,27 was not induced
in U937 cells by VV at mRNA level (our unpublished
data). Thus,  vaccinia  virus  infection  in  monocytes
seems  to  elicit  mainly  proinflammaroty  cytokines,
like, IL-1, TNFa and IL-12.
Endothelial cells play a key role in viral tropism in
vivo as they are directly exposed to the circulating
blood. Vaccinia virus infection of primary cultures of
endothelial cells showed very early up-regulation of
specific transcripts (at 2h) followed by an increase in
IL-6 secretion at 6h (Fig. 4), therefore it is suggested
that endothelial cells are more susceptible to vaccinia
virus  infection  than  fibroblasts  and  monocytic  cell
line in which the effect of similar infectious doses of
the virus was delayed.
Transcription factor NF-k B is crucial in activating
the transcription of genes encoding proinflammatory
cytokines, therefore vaccinia virus induced IL-6 and
TNFa production can be in part explained by rapid
increase in NF-k B-DNA binding activity found in U937
and HUVEC (Fig. 5), and this is the first report on VV
effects on the transcription factor binding.6
Since this is in vitro study, it would be difficult to
relate the results of our studies directly to vaccinia
virus infection in vivo. When a virus induces moder-
ate  amounts  of  cytokines,  it  may  be  beneficial  by
eliciting an immediate antiviral response, but it may
cause adverse effects when cytokine release is highly
elevated by bacterial products (LPS). Our data (Fig. 2)
suggest that the well-known severe manifestations of
combined virus-bacterial infections28 may be due, at
least in part, to an enhanced release of the endoge-
nous pyrogens TNFa and IL-1 which both may lead
upon introduction into circulation to an inflammatory
response  with  high  fever,  shock  syndromes,  and
tissue damage.29
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